# Solvay Pharmaceuticals clinical trials: 86 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 86 trials with Solvay Pharmaceuticals as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Solvay Pharmaceuticals: 86 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/solvay-pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 86
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 86, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 23, 2010 | NCT01109758 | Effects of Fenofibrate on Gene Expression in Healthy Volunteers | Solvay Pharmaceuticals | Phase 1 | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01109758) |
| March 17, 2010 | NCT01088594 | A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In... | Solvay Pharmaceuticals | Phase 1 | Completed | Type 2 Diabetes Mellitus | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01088594) |
| January 8, 2010 | NCT01044524 | Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion | Solvay Pharmaceuticals | Phase 1 | Completed | Pharmacology, Clinical | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01044524) |
| October 21, 2009 | NCT00998933 | Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure | Solvay Pharmaceuticals | Phase 1 | Completed | Hypogonadism | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00998933) |
| June 19, 2009 | NCT00924430 | Interaction Study SLV337/Simvastatin | Solvay Pharmaceuticals | Phase 1 | Completed | Type 2 Diabetes Mellitus | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00924430) |
| April 24, 2009 | NCT00887445 | First in Man Study With SLV341 | Solvay Pharmaceuticals | Phase 1 | Terminated | Diabetes | 87 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00887445) |
| April 22, 2009 | NCT00885989 | Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers | Solvay Pharmaceuticals | Phase 1 | Completed | Healthy | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00885989) |
| January 5, 2009 | NCT00816829 | Effect of Fenofibrate on Sleep Apnea Syndrome | Solvay Pharmaceuticals | Phase 2 | Terminated | Dyslipidemia, Sleep Apnea Syndrome, Overweight, Obesity | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00816829) |
| October 20, 2008 | NCT00775528 | Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis | Solvay Pharmaceuticals | Phase 3 | Completed | Cystic Fibrosis, Pancreatic Exocrine Insufficiency | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00775528) |
| August 29, 2008 | NCT00744341 | Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure | Solvay Pharmaceuticals | Phase 2 | Terminated | Acute Decompensated Heart Failure; Renal Dysfunction | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00744341) |
| June 23, 2008 | NCT00703755 | A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients... | Solvay Pharmaceuticals | Phase 2 | Completed | Patients With Metabolic Syndrome | 2,288 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00703755) |
| June 23, 2008 | NCT00703482 | A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on... | Solvay Pharmaceuticals | Phase 2 | Completed | Patients With Type 2 Diabetes | 278 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00703482) |
| June 5, 2008 | NCT00690820 | Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) | Solvay Pharmaceuticals | Phase 3 | Completed | Cystic Fibrosis, Pancreatic Exocrine Insufficiency | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00690820) |
| March 25, 2008 | NCT00642512 | Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting | Solvay Pharmaceuticals | Phase 3 | Completed | Chemotherapy Induced Nausea and Vomiting | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00642512) |
| March 25, 2008 | NCT00642499 | Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting | Solvay Pharmaceuticals | Phase 2 | Completed | Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting, HIV Infections | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00642499) |
| March 6, 2008 | NCT00630279 | Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis | Solvay Pharmaceuticals | Phase 2 | Terminated | Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00630279) |
| January 23, 2008 | NCT00599443 | Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 Years | Solvay Pharmaceuticals | Phase 1 | Completed | Healthy | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00599443) |
| January 23, 2008 | NCT00598910 | Effect of Omacor on Triglycerides in HIV Infected Subjects | Solvay Pharmaceuticals | Phase 4 | Terminated | Hyper-Triglyceridemia | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00598910) |
| December 5, 2007 | NCT00568009 | Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart... | Solvay Pharmaceuticals | Observational | Terminated | Congestive Heart Failure | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00568009) |
| November 21, 2007 | NCT00562237 | Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine | Solvay Pharmaceuticals | Phase 1 | Terminated | Healthy Subjects | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00562237) |
| October 15, 2007 | NCT00543647 | Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy People | Solvay Pharmaceuticals | Phase 1 | Completed | Healthy Volunteers | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00543647) |
| October 10, 2007 | NCT00541567 | BMS-646256 in Obese and Overweight Type 2 Diabetics | Solvay Pharmaceuticals | Phase 2/3 | Withdrawn | Obesity and Type 2 Diabetes | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00541567) |
| August 2, 2007 | NCT00510484 | Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis | Solvay Pharmaceuticals | Phase 3 | Completed | Cystic Fibrosis | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00510484) |
| June 22, 2007 | NCT00490178 | Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia | Solvay Pharmaceuticals | Phase 3 | Completed | Diabetes Mellitus, Type 2, Dyslipidemia | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00490178) |
| May 30, 2007 | NCT00479921 | Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe | Solvay Pharmaceuticals | Phase 3 | Completed | Healthy Volunteers | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00479921) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 11 |
| Phase 2 | 22 |
| Phase 2/3 | 3 |
| Phase 3 | 39 |
| Phase 4 | 9 |
| Not applicable | 1 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 69 |
| Terminated | 15 |
| Withdrawn | 2 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 8 |
| Diabetes Mellitus, Type 2 | 7 |
| Dyslipidemias | 7 |
| Parkinson Disease | 7 |
| Psychotic Disorders | 5 |
| Exocrine Pancreatic Insufficiency | 5 |
| Glucose Metabolism Disorders | 4 |
| Hypertension | 4 |
| Diabetes Mellitus | 4 |
| Hypogonadism | 4 |
| Influenza, Human | 4 |
| Obesity | 3 |
| Atrial Fibrillation | 3 |
| Atrial Flutter | 3 |
| Cystic Fibrosis | 3 |
| Hyperlipidemias | 3 |
| Heart Failure | 2 |
| Renal Insufficiency | 2 |
| Vomiting | 2 |
| Nausea | 2 |
| Pancreatitis, Chronic | 2 |
| HIV Infections | 2 |
| Body Weight Changes | 1 |
| Weight Loss | 1 |
| Bipolar Disorder | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [B2B oil and gas companies in the United States](https://specstream.ai/data/businesses/b2b-oil-and-gas-companies/united-states)
- [Workers compensation law firms in the United States](https://specstream.ai/data/businesses/workers-compensation-law-firms/united-states)
- [Tools wholesalers in the United States](https://specstream.ai/data/businesses/tools-wholesalers/united-states)
- [Shared office spaces in the United States](https://specstream.ai/data/businesses/shared-office-spaces/united-states)
- [Pressure washing companies in the United States](https://specstream.ai/data/businesses/pressure-washing-companies/united-states)
